Cyclerion Therapeutics Stock Momentum Indicators Average Directional Movement Index
| CYCN Stock | USD 1.36 0.09 6.21% |
| Symbol |
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The average directional index (ADX) measures the strength of a prevailing trend of Cyclerion Therapeutics and whether movement exists in the market. The ADX is measured on a scale of 0 to 100. A low Cyclerion Therapeutics ADX value usually indicates a non-trending market with low volumes, whereas a cross above 20 may indicate the start of a trend. If the ADX is over 40 and begins to fall, it can indicate the slowdown of a current trend. This indicator can also be used to identify non-trending markets, or a deterioration of an ongoing trend. Although market direction is important in its calculation, the ADX is not a directional indicator
Cyclerion Therapeutics Technical Analysis Modules
Most technical analysis of Cyclerion Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cyclerion from various momentum indicators to cycle indicators. When you analyze Cyclerion charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Cyclerion Therapeutics Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cyclerion Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cyclerion Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Cyclerion Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cyclerion Therapeutics's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Cyclerion Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Cyclerion Therapeutics, we also check how macroeconomic factors affect Cyclerion Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2022 | 2023 | 2024 (projected) | Payables Turnover | 0.0219 | 0.0252 | 0.0239 | Days Of Inventory On Hand | 4.5K | 4.1K | 2.1K |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cyclerion Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cyclerion Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cyclerion Therapeutics' short interest history, or implied volatility extrapolated from Cyclerion Therapeutics options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Entertainment Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | Momentum Invested over 60 shares | |
 | Impulse Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | Corona Opportunity Invested few shares | |
 | Investor Favorites Invested few shares | |
 | Automobiles and Trucks Invested over 50 shares | |
 | Macroaxis Picks Invested over 30 shares | |
 | Business Services Invested few shares | |
 | Manufacturing Invested over 30 shares | |
 | Baby Boomer Prospects Invested over 60 shares | |
 | Hedge Favorites Invested few shares |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cyclerion Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Cyclerion Stock, please use our How to Invest in Cyclerion Therapeutics guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cyclerion Therapeutics. If investors know Cyclerion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cyclerion Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.11) | Revenue Per Share 0.586 | Quarterly Revenue Growth 0.141 | Return On Assets (0.47) | Return On Equity (1.50) |
The market value of Cyclerion Therapeutics is measured differently than its book value, which is the value of Cyclerion that is recorded on the company's balance sheet. Investors also form their own opinion of Cyclerion Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cyclerion Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cyclerion Therapeutics' market value can be influenced by many factors that don't directly affect Cyclerion Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cyclerion Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cyclerion Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cyclerion Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.